You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the SODIUM PHENYLACETATE AND SODIUM BENZOATE (sodium benzoate; sodium phenylacetate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR SODIUM PHENYLACETATE AND SODIUM BENZOATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004767 ↗	Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders	Completed	Johns Hopkins University	Phase 2	1985-01-01	OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
NCT00004767 ↗	Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders	Completed	National Center for Research Resources (NCRR)	Phase 2	1985-01-01	OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
NCT00597909 ↗	Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy	Terminated	Horizon Pharma Ireland, Ltd., Dublin Ireland	Phase 2	2007-12-01	The primary purpose of this study is to evaluate the safety and effectiveness of Ammonul® in subjects who become hospitalized with Grade 3 or 4 hepatic encephalopathy (HE).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Condition Name

Chart
Table

Condition Name for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Intervention	Trials
Healthy	1
Healthy Volunteers	1
Hepatic Encephalopathy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Intervention	Trials
Hepatic Encephalopathy	1
Brain Diseases	1
Urea Cycle Disorders, Inborn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Trials by Country

Map
Table

Trials by Country for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Location	Trials
United States	2
Japan	1
Ukraine	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Location	Trials
Texas	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Clinical Trial Phase	Trials
Phase 2	2
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Clinical Trial Phase	Trials
Completed	3
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Sponsor Name

Chart
Table

Sponsor Name for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Sponsor	Trials
Horizon Pharma Ireland, Ltd., Dublin Ireland	2
Ucyclyd Pharma, Inc.	1
Takeda	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Sponsor	Trials
Industry	3
Other	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.